Terkko Navigator / European Urology

Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study

Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy

Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.03.035

Is Urethrotomy as Good as Urethroplasty in Men with Recurrent Bulbar Urethral Strictures?

National Quality Improvement Program in Transurethral Resection of Bladder Tumor: A Model for the Rest of Us, Even if We Cannot Share All Results

Neoadjuvant Intravesical Therapy for Non–muscle-invasive Bladder Cancer: A New Approach for Old Agents?

The Fallacy of “Definitive Therapy” for Prostate Cancer

Molecular Subtypes of T1 Bladder Cancer: Biomolecular Characteristics Versus Clinical Utility

Prostate-specific Antigen to Predict Early Success of Focal Therapy: Focusing on Appropriate Endpoints

What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort

What Are We Missing? Magnetic Resonance Imaging–negative Clinically Significant Prostate Cancer in PROMIS

Combined Cell-free DNA and RNA Profiling of the Androgen Receptor: Clinical Utility of a Novel Multianalyte Liquid Biopsy Assay for Metastatic Prostate Cancer

Congress Calendar

Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol. In press: C

Reply to Emre Karabay and İlker Tınay’s Letter to the Editor re: Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of t

Identification of Differential Tumor Subtypes of T1 Bladder Cancer

Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo’s Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer:

FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†

Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614–27

Re: Marc-Oliver Grimm, Antione G. van der Heijden, Marc Colombel, et al. Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Asso

Introduction of Telemedicine During the COVID-19 Pandemic: A Challenge for Now, an Opportunity for the Future

Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort

Re: Giovanni Lavorgna, Riccardo Vago, Francesco Montorsi, Andrea Salonia. Surnames in Y-Chromosome–related Diseases: A New Tool for the Urologist? Eur Urol 2020;77:767–8

Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04

Telemedicine and Smart Working: Recommendations of the European Association of Urology

Best Practices in Robotic-assisted Repair of Vesicovaginal Fistula: A Consensus Report from the European Association of Urology Robotic Urology Section Scientific Working Group for Reconstructive Urology

Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multi-cent

Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll’s Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A

More Knowledge to Better Predict?

Elucidating Durable Responses to Immune Checkpoint Inhibition

DNA Repair and Prostate Cancer: A Field Ripe for Harvest

Re: A Clonal Expression Biomarker Associates with Lung Cancer Mortality

Re: Lan Zhu, Nianqiao Gong, Bin Liu, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol 2020;77:748–54

Mutiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer

Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast’s Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is

ProstaTrend—A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer

Re: Greater Utility of Molecular Subtype Rather than Epithelial-to-mesenchymal Transition (EMT) Markers for Prognosis in High-risk Non-muscle-invasive (HGT1) Bladder Cancer

Undergraduate Urology Education: A Fundamental Pillar in Building the Next Generation of Urologists

Re: Do Patients with Stage 3–5 Chronic Kidney Disease Benefit from Ischaemia-sparing Techniques During Partial Nephrectomy?

Re: Olaparib for Metastatic Castration-resistant Prostate Cancer

Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen

Erratum to ‘Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received’ [European Urology 77 (2020) 320–330]

Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis

Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series

Re: Reconsidering Prostate Cancer Mortality - The Future of PSA Screening: Against increasing PSA threshold to 10 ng/ml

Re: Platinum-based Chemotherapy in Metastatic Prostate Cancer with DNA Repair Gene Alterations

Prostate-specific Membrane Antigen Positron Emission Tomography Scans Before Curative Treatment: Ready for Prime Time?

Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts